How Disconnected Systems Cost MedTech Companies

Clinical trials generate a ton of information across every part of a MedTech organization, from study start up through conclusion. The trouble comes when departments rely on different systems to store and organize this information: a patchwork of systems means a disconnected process. 

ClinOps might record a study update in one system, causing another team to miss that information while trying to make a decision. Study leadership finds that they have to cross-reference several databases to make sure everything’s up to date. Trials become messy and inefficient, causing delays in product rollout. 

Why are MedTech organizations still working with a thrown together combination of legacy CTMS tech, supplemented with spreadsheets, personal databases, email chains, and specialized apps? Each tool might serve its intended purpose, but the gaps between them are where details fall through. If you have to move and check and interpret data before you can use it, it’s become functionally useless by the time you’ve finished. 

The problem is that it’s easy to overlook the mundane, everyday system faults as it’s hard to turn it into a line item on a budget. These processes creep into hours of duplicate work and delayed reporting, inconsistent information and slower decision-making. 

For MedTech companies, where clinical studies influence not only product development but regulatory activities, the consequences extend far beyond study administration. 

As organizations grow, new systems are often added to address specific needs. A legacy Clinical Trial Management System might have worked well when the company was small, but now it sits alongside tools for documents and regulatory work, with spreadsheets stretching in between. With an expanding portfolio, the problems start when information can’t easily move from one place to another. 

Without system interoperability, people become the connection between applications. They export reports manually and re-enter information in other systems, while sending updates and comparing records to make sure colleagues are working with the same data. 

An event as simple as a completed monitoring visit might be recorded in one system, but not the others. If that update doesn’t reach the people who need it, the project manager continues working from an earlier status while finance uses even older information for planning. Suddenly, as the project manager realizes there’s been an update, they have to double-work to accommodate the new data and update finance that they have to do the same. 

Multiply this across studies and sites and watch how increasing administrative burden becomes part of everyday operations. 

A huge problem immediately becomes apparent when we ask the question, “what gets lost when information arrives too late?” If an organization’s running studies across several regions, tiny pileups can start to appear without anyone noticing. Enrollment might begin to slow at several sites while monitoring activities fall behind schedule. Because of this, projected study costs begin to slowly rise. Viewed separately, none of these developments seem urgent—but taken together, they point to a potential operational problem that deserves attention. 

In a disconnected environment, recognizing that pattern takes time. Each department receives its own report and data and develops its own view of the situation. Eventually, someone has to bring those pieces together before leadership can see the broader picture. 

This is where real-time data flow comes in. When information moves between systems automatically as study activity occurs, teams have a more current basis for assessing performance. Instead of spending meetings comparing numbers and confirming which version is correct, they can focus on what the information means and what action is appropriate. 

For MedTech organizations, that distinction is particularly significant. A clinical study doesn’t exist in isolation. Its progress can influence product development and broader business decisions.

The cost of disconnected systems rarely stops at software. It accumulates through the hours people spend in workflows that could be automated: preparing reports, reconciling records, correcting inconsistencies, playing phone-tag with colleagues and tracking down personal spreadsheets. While those activities seem minor individually, they become a recurring operational expense across a portfolio of studies. Time adds up quickly. 

There’s a less visible cost, too. Time spent reconstructing information is time that can’t be spent interpreting it. Meetings that are devoted to reconciling spreadsheets are meetings that have less time for talking over study risks or deciding how to respond to them. 

This is what makes legacy CTMS replacement more than a technology decision: it’s a question of how much manual effort and wasted time an organization is willing to build into its clinical operations. 

As organizations and portfolios grow, disconnected systems become increasingly difficult to manage. More studies mean more data moving between people and applications, and without a connected infrastructure, this translates to increasingly more human intervention. 

If your organization’s considering legacy CTMS migration, the important question is therefore not only whether the existing platform still works, but if the surrounding process still makes sense. How many times does information have to be entered? How long does it take to produce a view of a study you can trust is the most up-to-date from all sides? How often are different departments reconciling their numbers before they can make a decision? When you look at the time inherent in all of these processes, it’s easy to see how the hidden costs add up. 

A modern CTMS for MedTech can provide a concrete foundation, with system interoperability supporting data movement and a shared view of study activity. The goal is to reduce the amount of work required to make existing information useful—so your team can get back to the work that makes a difference.

• System interoperability reduces the manual effort created by disconnected clinical systems. 
• Real-time clinical trial data gives teams a more current view of study performance. 
• Shared information supports stronger departmental collaboration across the organization. 
• Legacy CTMS replacement can reduce the hidden costs inherent in reconciliation and duplicate work. 
• A CTMS optimized for MedTech companies offers a connected approach to managing growing study portfolios. 

If you're relying on a CTMS that's been in place for years, it's worth asking a simple question: is it helping your teams make decisions faster, or just recording what's already happened?

At BSI Life Sciences, we work with enterprise sponsors looking to modernize their clinical operations without disrupting ongoing studies. If you'd like to explore what's possible, let’s start the conversation!